Delivery Order SPE2DB20D1100-SPE2DB24FD9A4

Award Date 9/18/24
Potential Completion Date 10/9/24
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $19,341.24 firm fixed-price contract is for the supply of ENHERTU 100 MG VIALS, a pharmaceutical product. The delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,777.00 firm fixed-price contract is for the supply of ENHERTU 100 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of April 16, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,332.40, is for the procurement of ENHERTU 100 MG VIALS, a specialty pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENHERTU 100 MG vials. The delivery order, valued at $19,341.24, is a firm-fixed-price contract with an ultimate completion date of October 18, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
This federal contract award, valued at $14,221.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENHERTU 100 MG VIALS, a pharmaceutical product, with a performance period ending on May 29, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,416.30 firm fixed price contract is for the supply of ENHERTU 100 MG vials, a specialty oncology medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The $8,058.85 contract is for the delivery of ENHERTU 100 MG vials and is set to be completed by February 16, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger $999,999,999.00 indefinite delivery...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution services company. The $21,614.96 award is for the provision of ENHERTU 100 MG vials, a specialty pharmaceutical product, with a completion date of March 13, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the provision of ENHERTU 100 MG vials. The contract has a ceiling value of $16,117.70 and runs through August 28, 2024. AmerisourceBergen is a major pharmaceutical distributor that supplies a wide range of essential medical commodities to various federal agencies, including the military, veterans' healthcare facilities, and other government healthcare providers. This delivery order is...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENHERTU 100 MG VIALS, a medical supply, with a ceiling value of $21,332.40. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is April 7, 2025. The contract is not designated with a set-aside. AmerisourceBergen...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD9A4
    Delivery Order

This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $19,341.24 firm fixed price contract is for the supply of ENHERTU 100 MG vials, a specialty pharmaceutical product. This delivery order falls under a larger Indefinite Delivery Contract valued up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of medical commodities in support of military treatment programs and facilities worldwide. The contract does not have a set-aside designation. Amerisourcebergen, as a major pharmaceutical distributor, leverages its extensive supply chain network to supply critical medications and medical supplies to various federal agencies and healthcare programs, including the military.

Generated 12/18/24, 9:42 AM